Valuation check: SAN.PA's PEG ratio is -23.96, below the Healthcare sector average of 11.77.
Get informed when a big investor buys or sells
+ Follow-23.96
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Sanofi (SAN.PA) currently reports a PEG ratio of -23.96. That is below the Healthcare sector average of 11.77. Use the charts on this page to explore Sanofi's PEG ratio history and peer comparisons.
Sanofi's PEG ratio of -23.96 is lower than the Healthcare sector average of 11.77. That is roughly 303.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Sanofi's market price to a fundamental measure such as earnings, sales, or book value. At -23.96, SAN.PA can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -23.96, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.77. From there, open related valuation or income-statement pages for Sanofi, and consider following SAN.PA for alerts when major investors trade the stock.
Sanofi is classified in the Healthcare sector. On PEG ratio, it currently shows -23.96 versus a sector average near 11.77. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SAN.PA with unrelated industries.